However, several studies have confirmed that SERPINE1 was significantly upregulated in a variety of malignancies, including glioblastoma, esophageal squamous carcinoma, breast cancer, gastric cancer, bladder cancer, and oral squamous carcinoma. This evidence concerns the gene SERPINE1 and breast carcinoma.